Episealer®-implantatet lyfts fram i tre vetenskapliga publikationer
Episurf Medical ABs (NASDAQ: EPIS B) knäimplantat Episealer® har nyligen diskuterats i tre expertgranskade (eng: peer-reviewed) vetenskapliga publikationer. Samtliga tre publikationer, “Current surgical options for the treatment of symptomatic articular cartilage lesions of the knee” (Biant, L.C. et al., Orthopaedics and Trauma, 2019. 33(2): 127-132), “Focal knee resurfacing” (Nahas, S., et al., Orthopaedics and Trauma, 2019. 33(2): 133-139) och “What future in the treatment of osteochondral knee defects?” (D’Ambrosi, R., et al., Annals of Translational Medicine, 2018, 6, Suppl 2, S100)